FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today!

About | Sample | Privacy
Related Topics >> GlaxoSmithKline | Merck | Cervarix | Gardasil

Brits to vaccinate schoolgirls against HPV

Tools

The British government just made Merck's day--or was it GlaxoSmithKline's? U.K. schoolgirls will be vaccinated against the human papilloma virus that causes cervical cancer. And it's not just the 12- and 13-year-olds initially recommended to get the shot, but young women up to age 18, too.

The government stopped short of recommending which version of the vaccine to use. Both Gardasil, made by Merck and Sanofi Pasteur, and Cervarix, made by Glaxo, are approved for use in the U.K. Glaxo's version launched only recently, while Merck has had more time to get a toehold in the market.

- read the story at the BBC's website

More stories about GlaxoSmithKline   Merck   Cervarix   Gardasil  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 43 + 7?
To combat spam, please solve the math question above.